CURIUM FDA Approval NDA 018058

NDA 018058

CURIUM

FDA Drug Application

Application #018058

Application Sponsors

NDA 018058CURIUM

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION2mCi/ML0GALLIUM CITRATE GA 67GALLIUM CITRATE GA-67

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1979-02-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1980-07-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1981-12-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1982-05-07STANDARD
LABELING; LabelingSUPPL5AP1984-03-08
LABELING; LabelingSUPPL7AP1982-09-27
LABELING; LabelingSUPPL8AP1982-09-14
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1985-11-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2014-03-19STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL10Null0
SUPPL13Null0

TE Codes

001PrescriptionBS

CDER Filings

CURIUM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18058
            [companyName] => CURIUM
            [docInserts] => ["",""]
            [products] => [{"drugName":"GALLIUM CITRATE GA 67","activeIngredients":"GALLIUM CITRATE GA-67","strength":"2mCi\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"GALLIUM CITRATE GA 67","submission":"GALLIUM CITRATE GA-67","actionType":"2mCi\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.